Arrowhead Pharmaceuticals (ARWR) Construction in Progress (2021 - 2023)

Arrowhead Pharmaceuticals (ARWR) has 3 years of Construction in Progress data on file, last reported at $166.7 million in Q3 2023.

• Quarterly Construction in Progress rose 195.63% year-over-year to $166.7 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $166.7 million (up 195.63% YoY) and the FY2023 annual result came in at $166.7 million, up 195.63% from the prior year.
• Construction in Progress improved to $166.7 million in Q3 2023, from $118.3 million in the prior quarter.
• In the past five years, Construction in Progress ranged from a high of $166.7 million in Q3 2023 to a low of $345000.0 in Q3 2021.
• A 3-year average of $65.6 million and a median of $56.4 million in 2022 frame the typical range for Construction in Progress.
• Annual changes were most pronounced in 2022 — Construction in Progress surged 16240.0% — and 2023, when it jumped 195.63%.
• Tracing ARWR's Construction in Progress over 3 years: stood at $2.2 million in 2021, then surged by 4092.15% to $90.2 million in 2022, then jumped by 84.73% to $166.7 million in 2023.
• The last three Construction in Progress figures came in at $166.7 million (Q3 2023), $118.3 million (Q2 2023), and $127.2 million (Q1 2023), per Business Quant data.